Minimally invasive oncologic surgery

Minimally invasive oncologic surgery

Minimally invasive oncologic surgery

On this page

🔑 Keyhole Cancer War: Minimally Invasive Oncologic Surgery

Minimally Invasive Surgery (MIS) uses laparoscopy or robotics for cancer resection via small incisions.

  • Patient Benefits: ↓ post-op pain, ↓ blood loss, ↓ hospital stay, faster recovery, better cosmesis.
  • Oncologic Mandates: Must adhere to the same principles as open surgery:
    • Complete tumor removal with negative margins (R0).
    • Adequate lymph node dissection.
    • Strict avoidance of tumor spillage.
  • Key Risks:
    • ⚠️ Port-site metastasis: A major concern if poor technique leads to tumor seeding.
    • Loss of tactile feedback; longer initial operative times.

⭐ For many cancers (e.g., colorectal, prostate, endometrial), MIS offers equivalent long-term oncologic outcomes (survival) compared to open surgery, but with superior short-term recovery profiles.

Laparoscopic port placement and surgical setup

🤖 Management - The Good, Bad, & Robotic

  • Laparoscopic ("The Good"):
      • Benefits: ↓ pain, ↓ blood loss, ↓ hospital stay, faster recovery, improved cosmesis.
      • Goal: Achieve same oncologic outcomes as open surgery (en-bloc resection, negative margins, adequate lymphadenectomy).
  • Challenges ("The Bad"):
      • Limitations: Loss of haptic (tactile) feedback, 2D vision, steep learning curve.
      • ⚠️ CO₂ Insufflation: Can cause hypercarbia, acidosis, and ↓ venous return. Caution in patients with severe cardiopulmonary disease.
      • Port-site Metastasis: Historically a concern; now rare with specimen retrieval bags.
  • Robotic ("The Robotic"):
      • Advantages: 3D magnified vision, wristed instruments (7 degrees of freedom), tremor filtration.
      • Best Use: Complex dissection in confined spaces (e.g., prostatectomy, low anterior resection).
      • Downside: ↑ cost, longer setup time.

⭐ For many cancers (e.g., colon, prostate, endometrial), MIS offers equivalent long-term oncologic outcomes (survival) to open surgery, with improved short-term morbidity.

Robotic surgical system components

⚠️ Complications - Tiny Incisions, Big Concerns

  • Port-Site Metastasis (PSM):
    • Tumor cell implantation at trocar sites.
    • Mechanisms: Direct contamination during specimen extraction, aerosolization of tumor cells ("chimney effect" with CO₂ leakage).
    • Prevention: Use of specimen retrieval bags, minimizing tumor manipulation.
  • Gas-Related (CO₂ Insufflation):
    • Gas Embolism: Rare but fatal. Sudden ↓ETCO₂, hypotension, "mill-wheel" murmur.
    • Subcutaneous Emphysema: Usually benign; resolves spontaneously.
    • Pneumothorax/Pneumomediastinum: Risk in upper abdominal/thoracic cases.
  • Access & Instrument Injuries:
    • Trocar Injury: Vascular (e.g., epigastric artery) or visceral (bowel) damage.
    • Thermal Injury: Unrecognized burns from electrocautery.

Port-site metastasis (PSM) is a unique, feared complication that challenges the oncologic safety of MIS. Proper technique, including specimen containment, is critical to prevention.

🤏 When to Go Small

The decision for Minimally Invasive Surgery (MIS) hinges on achieving oncologic goals with less morbidity.

  • Core Principle: MIS is an option only when it achieves the same oncologic outcome (R0 resection, adequate nodes) as open surgery.
  • Favorable Factors:
    • Tumor: Early-stage, localized, non-bulky.
    • Patient: Significant comorbidities, obesity.
  • Contraindications:
    • Bulky/invasive disease.
    • High risk of tumor spillage.
    • Hemodynamic instability.
    • Inadequate surgeon experience.

⭐ The key is oncologic non-inferiority. MIS must match open surgery's survival rates before its benefits (↓ pain, ↓ length of stay, faster recovery) make it the preferred approach.

Open, Laparoscopic, and Robotic Surgery Incisions

⚡ Biggest Takeaways

  • MIOS (laparoscopic/robotic) must achieve equivalent oncologic outcomes (survival, margins) to open surgery.
  • Major benefits include ↓ pain, ↓ blood loss, shorter hospital stays, and faster recovery.
  • Key risks involve a steep learning curve, longer operative times, and loss of tactile feedback.
  • Port-site metastasis is a rare complication, mitigated by using specimen retrieval bags.
  • Strict adherence to oncologic principles-en bloc resection, negative margins, and adequate lymphadenectomy-is paramount.
  • CO2 pneumoperitoneum can cause hypercarbia and increased intracranial pressure.

Practice Questions: Minimally invasive oncologic surgery

Test your understanding with these related questions

A 64-year-old woman presents to the surgical oncology clinic as a new patient for evaluation of recently diagnosed breast cancer. She has a medical history of type 2 diabetes mellitus for which she takes metformin. Her surgical history is a total knee arthroplasty 7 years ago. Her family history is insignificant. Physical examination is notable for an irregular nodule near the surface of her right breast. Her primary concern today is which surgical approach will be chosen to remove her breast cancer. Which of the following procedures involves the removal of a portion of a breast?

1 of 5

Flashcards: Minimally invasive oncologic surgery

1/5

Treatment for localized renal cell carcinoma is _____

TAP TO REVEAL ANSWER

Treatment for localized renal cell carcinoma is _____

surgical resection

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial